Recombinant liposomal factor VIIa - RecolyAlternative Names: LongSeven; NecLip-rFVIIa
Latest Information Update: 14 Sep 2015
At a glance
- Originator Recoly
- Class Blood coagulation factors; Coagulants; Recombinant proteins; Serine endopeptidases
- Mechanism of Action Factor VIIa stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Haemophilia A
Most Recent Events
- 14 Sep 2015 Discontinued - Phase-I/II for Haemophilia A in Russia (IV)